Clinical Roundup AI mapping technology outperforms MRI in predicting prostate cancer spread, study shows May 02, 2025Vol.51 No.17
Drugs & Targets CHMP adopts positive opinion for Adcetris + ECADD for newly diagnosed stage IIb/III/IV Hodgkin lymphoma May 02, 2025Vol.51 No.17
Drugs & Targets CHMP adopts positive opinion on Calquence-based regimens for CLL May 02, 2025Vol.51 No.17
Conversation with The Cancer Letter Steven Libutti tells us about building a $900 million cancer hospital for Rutgers RWJBarnabas Health April 25, 2025Vol.51 No.16By Paul Goldberg
Guest Editorial In her own words: Rathmell reflects on her priorities and values—and encourages everyone to do the same April 25, 2025Vol.51 No.16By W. Kimryn Rathmell
Regulatory News Makary vows to speed up drug approvals and end FDA’s “cozy” relationship with industryCommissioner promises to protect scientific integrity while bringing in “fresh” MAHA ideas April 25, 2025Vol.51 No.16By Claire Marie Porter
Guest Editorial Regulation must keep up with scientific advances April 25, 2025Vol.51 No.16By Richard M. Goldberg
Cancer Policy White House preliminary budget document provides no funds for highly impactful CDC cancer registries program April 25, 2025Vol.51 No.16By Paul Goldberg
